Press Releases :: VolitionRx Ltd (VNRX)

Jul 22, 2021 • 8:00 AM EDT Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

May 11, 2021 • 4:10 PM EDT VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update

May 6, 2021 • 8:15 AM EDT VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update

Mar 31, 2021 • 8:30 AM EDT VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper

Mar 30, 2021 • 8:30 AM EDT VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary

Mar 29, 2021 • 4:10 PM EDT VolitionRx Limited Appoints Two New Directors

Mar 22, 2021 • 4:10 PM EDT VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update

Mar 17, 2021 • 8:00 AM EDT New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis

Mar 16, 2021 • 8:30 AM EDT VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update

Mar 8, 2021 • 4:15 PM EST VolitionRx Limited to Present at Conferences in March 2021